Delivery Order SPE2DB22D3010-SPE2DB24FP1XR
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,400.00 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an active indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $10,170.76 award has a completion date of March 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $1,052.00, has a completion date of March 1, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.0.5ML. The $13,469.22 delivery order has a completion date of February 1, 2024. AmerisourceBergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) valued up to...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $3,419.00 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not operating under a set-aside designation. This award is part of a larger indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product called MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,600.54 and a performance period through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which does not have a set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $1,052 contract has a period of performance through March 20, 2024. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as AmerisourceBergen, is the prime contractor. This delivery order is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,630.00 order has a completion date of February 20, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,052.00 to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $44,015.53 contract has an ultimate completion date of April 8, 2024 and is not associated with any set-aside designation. AmerisourceBergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical in...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP1XRDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MOUNJARO 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,323.67, has an ultimate completion date of March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This award does not have a set-aside designation.
Generated 6/14/24, 10:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/15/24 |